{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:47:00Z","timestamp":1792619220184,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T00:00:00Z","timestamp":1496620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12185-017-2268-3","type":"journal-article","created":{"date-parts":[[2017,6,5]],"date-time":"2017-06-05T01:14:00Z","timestamp":1496625240000},"page":"718-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Steroid-resistant autoimmune myelofibrosis in a patient with autoimmune hepatitis and Evans syndrome complicated with increased expression of TGF-\u03b2 in the bone marrow: a case report"],"prefix":"10.1007","volume":"106","author":[{"given":"Hiroshi","family":"Ohkawara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Shichishima-Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Fukatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,5]]},"reference":[{"key":"2268_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajh.10258","volume":"72","author":"V Pullarkat","year":"2003","unstructured":"Pullarkat V, Bass RD, Gong JZ, Feinstein DI, Brynes RK. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome. Am J Hematol. 2003;72:8\u201312.","journal-title":"Am J Hematol"},{"key":"2268_CR2","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.humpath.2014.07.017","volume":"45","author":"ME Vergara-Lluri","year":"2014","unstructured":"Vergara-Lluri ME, Piatek CI, Pullarkat V, Siddiqi IN, O\u2019Connell C, Feinstein DI, Brynes RK. Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature. Hum Pathol. 2014;45:2183\u201391.","journal-title":"Hum Pathol"},{"key":"2268_CR3","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90:1128\u201332.","journal-title":"Haematologica"},{"key":"2268_CR4","first-page":"2016","volume":"9","author":"Y Abaza","year":"2016","unstructured":"Abaza Y, Yin CC, Bueso-Ramos CE, Wang SA, Verstovsek S. Primary autoimmune myelofibrosis: a case report and review of the literature. Int J Hematol. 2016;9:2016.","journal-title":"Int J Hematol"},{"key":"2268_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00313029500169073","volume":"27","author":"R Ramakrishna","year":"1995","unstructured":"Ramakrishna R, Kyle PW, Day PJ, Manoharan A. Evans\u2019 syndrome, myelofibrosis and systemic lupus erythematosus: role of procollagens in myelofibrosis. Pathology. 1995;27:255\u20139.","journal-title":"Pathology"},{"key":"2268_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0961203315615221","volume":"25","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Chowdhary VR, Davis MD, Makol A. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil. Lupus. 2016;25:427\u201330.","journal-title":"Lupus"},{"key":"2268_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.20439","volume":"81","author":"JS Harrison","year":"2006","unstructured":"Harrison JS, Corcoran KE, Joshi D, Sophacleus C, Rameshwar P. Peripheral monocytes and CD4+ cells are potential sources for increased circulating levels of TGF-\u03b2 and substance P in autoimmune myelofibrosis. Am J Hematol. 2006;81:51\u20138.","journal-title":"Am J Hematol"},{"key":"2268_CR8","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","volume":"107","author":"M Dong","year":"2006","unstructured":"Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood. 2006;107:4589\u201396.","journal-title":"Blood"},{"key":"2268_CR9","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, Them NC, Berg T, Gisslinger B, Pietra D, Chen D, Vladimer GI, Bagienski K, Milanesi C, Casetti IC, Sant\u2019Antonio E, Ferretti V, Elena C, Schischlik F, Cleary C, Six M, Schalling M, Sch\u00f6negger A, Bock C, Malcovati L, Pascutto C, Superti-Furga G, Cazzola M, Kralovics R. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369:2379\u201390.","journal-title":"N Engl J Med"},{"key":"2268_CR10","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood.V84.11.3785.bloodjournal84113785","volume":"84","author":"PC Bruin de","year":"1994","unstructured":"de Bruin PC, Kummer JA, van der Valk P, van Heerde P, Kluin PM, Willemze R, Ossenkoppele GJ, Radaszkiewicz T, Meijer CJ. Granzyme B expressing peripheral T-cell lymphomas: neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue localization. Blood. 1994;84:3785\u201391.","journal-title":"Blood"},{"key":"2268_CR11","first-page":"1893","volume":"150","author":"RE Felgar","year":"1997","unstructured":"Felgar RE, Macon WR, Kinney MC, Roberts S, Pasha T, Salhany KE. TIA-1 expression in lymphoid neoplasm: identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Am J Pathol. 1997;150:1893\u2013900.","journal-title":"Am J Pathol"},{"key":"2268_CR12","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","volume":"30","author":"RM Emanuel","year":"2012","unstructured":"Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hern\u00e1ndez-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L, Cahn JY, Harrison CN, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol. 2012;30:4098\u2013103.","journal-title":"J Clin Oncol"},{"key":"2268_CR13","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","volume":"62","author":"MP Manns","year":"2015","unstructured":"Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis-update 2015. J Hepatol. 2015;62:S100\u201311.","journal-title":"J Hepatol"},{"key":"2268_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2013.11.009","volume":"13","author":"R Liberal","year":"2014","unstructured":"Liberal R, Grant CR, Longhi MS, Mieli-Vergani G, Vergani D. Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev. 2014;13:435\u201340.","journal-title":"Autoimmun Rev"},{"key":"2268_CR15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/hepr.12530","volume":"46","author":"UB Kuzu","year":"2016","unstructured":"Kuzu UB, \u00d6zta\u015f E, Turhan N, Saygili F, Suna N, Yildiz H, Kaplan M, Akpinar MY, Akdo\u011fan M, Ka\u00e7ar S, Kili\u00e7 ZM, K\u00f6ksal A\u015e, \u00d6demi\u015f B, Kaya\u00e7etin E. Clinical and histological features of idiosyncratic liver injury: dilemma in diagnosis of autoimmune hepatitis. Hepatol Res. 2016;46:277\u201391.","journal-title":"Hepatol Res"},{"key":"2268_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bjhh.2016.04.003","volume":"38","author":"Campos P Melo de","year":"2016","unstructured":"de Melo Campos P. Primary myelofibrosis: current therapeutic options. Rev Bras Hematol Hemoter. 2016;38:257\u201363.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"2268_CR17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2141.2012.09179.x","volume":"158","author":"JT Reilly","year":"2012","unstructured":"Reilly JT, McMullin MF, Beer PA, Butt N, Conneally E, Duncombe A, Green AR, Michaeel NG, Gilleece MH, Hall GW, Knapper S, Mead A, Mesa RA, Sekhar M, Wilkins B, Harrison CN. Writing group: British Committee for Standards in Haematology. Guideline for the diagnosis and management of myelofibrosis. Br J Haematol. 2012;158:453\u201371.","journal-title":"Br J Haematol"},{"key":"2268_CR18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2006-12-064626","volume":"110","author":"SO Ciurea","year":"2007","unstructured":"Ciurea SO, Merchant D, Mahmud N, Ishii T, Zhao Y, Hu W, Bruno E, Barosi G, Xu M, Hoffman R. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood. 2007;110:986\u201393.","journal-title":"Blood"},{"key":"2268_CR19","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","volume":"114","author":"M Michel","year":"2009","unstructured":"Michel M, Chanet V, Dechartres A, Morin AS, Piette JC, Cirasino L, Emilia G, Zaja F, Ruggeri M, Andr\u00e8s E, Bierling P, Godeau B, Rodeghiero F. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009;114:3167\u201372.","journal-title":"Blood"},{"key":"2268_CR20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/096120339700600412","volume":"6","author":"A Aharon","year":"1997","unstructured":"Aharon A, Levy Y, Bar-Dayan Y, Afek A, Zandman-Goddard G, Skurnik Y. Successful treatment of early secondary myelofibrosis in SLE with IVIG. Lupus. 1997;6:408\u201311.","journal-title":"Lupus"},{"key":"2268_CR21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood-2008-01-131029","volume":"112","author":"B Godeau","year":"2008","unstructured":"Godeau B, Porcher R, Fain O, Lefr\u00e8re F, Fenaux P, Cheze S, Vekhoff A, Chauveheid MP, Stirnemann J, Galicier L, Bourgeois E, Haiat S, Varet B, Leporrier M, Papo T, Khellaf M, Michel M, Bierling P. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood. 2008;112:999\u20131004.","journal-title":"Blood"},{"key":"2268_CR22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00277-016-2605-2","volume":"95","author":"K Laribi","year":"2016","unstructured":"Laribi K, Bolle D, Ghnaya H, Sandu A, Besan\u00e7on A, Denizon N, Truong C, Pineau-Vincent F, de Materre AB. Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA. Ann Hematol. 2016;95:765\u20139.","journal-title":"Ann Hematol"},{"key":"2268_CR23","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/jgs.14188","volume":"64","author":"N Mumoli","year":"2016","unstructured":"Mumoli N, Giorgi-Pierfranceschi M, Ferretti A, Vitale J, Cei M. Acquired hemophilia treated using low-dose of rituximab. J Am Geriatr Soc. 2016;64:1744\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"2268_CR24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","volume":"108","author":"C Cutler","year":"2006","unstructured":"Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D, Klickstein LB, Levin J, Miller K, Reynolds C, Macdonell R, Pasek M, Lee SJ, Ho V, Soiffer R, Antin JH, Ritz J, Alyea E. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006;108:756\u201362.","journal-title":"Blood"},{"key":"2268_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/08916930903374600","volume":"43","author":"N Jacob","year":"2010","unstructured":"Jacob N, Stohl W. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2010;43:84\u201397.","journal-title":"Autoimmunity"},{"key":"2268_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","volume":"474","author":"M Shi","year":"2011","unstructured":"Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, Springer TA. Latent TGF-\u03b2 structure and activation. Nature. 2011;474:343\u20139.","journal-title":"Nature"},{"key":"2268_CR27","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2002-07-2341","volume":"101","author":"TL Reeder","year":"2003","unstructured":"Reeder TL, Bailey RJ, Dewald GW, Tefferi A. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. Blood. 2003;101:1981\u20133.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2268-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2268-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2268-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T08:24:05Z","timestamp":1602231845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2268-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2268-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,5]]}}}